PRM Prim, S.A.

13.44USD12.25 EUR · BME-0.41%Mkt Cap: 228.09M USDP/E: 15.91

Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs produ…

Key Statistics

Company
Market Cap228.09M USD
Enterprise Value221.93M USD
Revenue (TTM)274.91M USD
Gross Profit141.35M USD
Net Income (TTM)18.30M USD
Revenue/Share16.16 USD
Last Price13.44 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees958
CountryES
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINES0170884417
Valuation
P/E (Trailing)15.91
P/E (Forward)9.23
PEG—
EV/EBITDA8.08
EV/Revenue0.81
P/S0.83
P/B1.51
EPS (TTM)0.84 USD
EPS (Forward)1.46 USD
52W Range
13.278% of range15.25
52W High15.25 USD
52W Low13.27 USD
Profitability
Gross Margin51.18%
Oper. Margin6.88%
EBITDA Margin9.99%
Profit Margin6.63%
ROE12.12%
ROA8.49%
ROIC15.08%
ROCE17.17%
Growth
Revenue Growth-1.00%
Earnings Growth-34.90%
Cash Flow & Leverage
Operating CF40.29M USD
CapEx (TTM)13.51M USD
FCF Margin6.20%
FCF Yield7.47%
Net Debt-6.59M USD
Net Debt/EBITDA-0.24
Net Debt/FCF-0.39
Balance Sheet
Debt/Equity0.11
Current Ratio2.57
Quick Ratio1.39
Book Value/Sh8.87 USD
Cash/Share1.64 USD
Dividends
Fwd Div Rate0.58 USD
Trail. Div Rate0.44 USD
Div. Yield4.30%
5Y Avg Yield3.02%
Payout Ratio63.51%
Ex-Div DateJul 13, 2026
Pay Date—
Splits
Last Split2:1
Split DateFeb 20, 2006
Analyst Consensus
Rating—
Target (Mean)18.37 USD
Upside (mean)+36.7%
Target Range18.37 USD – 18.37 USD
# Analysts1
Ownership
Shares Out.16.98M
Float15.99M
Insiders59.76%
Institutions12.28%
Technical
SMA 5013.76 (-2.3%)
SMA 20014.24 (-5.7%)
Beta0.51
S&P 52W Chg12.00%
Avg Vol (30d)2.37K
Avg Vol (10d)2.63K
Technical Indicators
RSI (14)39.9
MACD-0.0787
MACD Signal-0.0778
MACD Hist.-0.0009
BB Upper13.91 USD
BB Middle13.62 USD
BB Lower13.33 USD
BB Width4.22%
ATR (14)0.2137 USD
Vol Ratio (20d)0.33x

About Prim (BME: PRM)

›

Prim (BME: PRM) is listed on the Bolsa de Madrid, where its shares trade in EUR. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 958 employees.

The shares were at 12.25 EUR on 19 November 2026, down 6.4% over 52 weeks. Its 52-week range is 12.10 EUR to 13.90 EUR: the price is 11.9% below the high and 1.2% above the low.

At a market capitalisation of 207.96M EUR, it trades at 15.9 times trailing earnings and 9.2 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a discount of 68% for PRM. It pays a dividend yielding 4.30% (it pays out 64% of its earnings), against a median of 0.93% among the dividend payers in that peer group.

Prim reports return on equity of 12.1%, an operating margin of 6.9% and revenue down 1.0% year over year.

It holds more cash than debt, a net cash position of 6.01M EUR. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. One analyst covers the stock; their mean price target of 16.75 EUR is 36.7% above the current price.